DAVID GONZALES: Open Payments
NPI 1588766919 · FORT WORTH, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,272 in 110 payments from 25 companies in 2025. Trend: 2023 $1,162 · 2024 $2,482 · 2025 $3,272
Food & beverage: $3,272
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $470 |
| Lilly USA, LLC | 9 | $444 |
| PFIZER INC. | 23 | $360 |
| AstraZeneca Pharmaceuticals LP | 9 | $348 |
| GlaxoSmithKline, LLC. | 17 | $288 |
| ABBVIE INC. | 14 | $187 |
| Abbott Laboratories | 1 | $176 |
| JAZZ PHARMACEUTICALS INC. | 1 | $128 |
| Amgen Inc. | 1 | $125 |
| Supernus Pharmaceuticals, Inc. | 1 | $122 |
Products named: Wegovy, JARDIANCE, NURTEC ODT, AIRSUPRA, FREESTYLE LIBRE 3, XYWAV, TRELEGY ELLIPTA, BREZTRI.
Industry payments across TX — which companies pay providers there.
